Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases
Intensity modulation
Clinical Sciences
Radiotherapy Planning
610
Clinical sciences
Health Informatics
Radiosurgery
03 medical and health sciences
Computer-Assisted
0302 clinical medicine
Humans
Neoplasm Metastasis
Stereotactic radiosurgery
Biomedical and Clinical Sciences
Gamma Knife
Brain Neoplasms
Radiotherapy Planning, Computer-Assisted
Brain metastases
Computer vision and multimedia computation
Radiotherapy Dosage
Nuclear Medicine & Medical Imaging
Radiology Nuclear Medicine and imaging
Surgery
Original Article
DOI:
10.1007/s11548-014-1001-4
Publication Date:
2014-04-19T04:22:07Z
AUTHORS (12)
ABSTRACT
Normal brain tissue doses have been shown to be strongly apparatus dependent for multi-target stereotactic radiosurgery. In this study, we investigated whether inter-target dose interplay effects across contemporary radiosurgical treatment platforms are responsible such an observation.For the subsets ([Formula: see text] and 12) of a total 12 targets were planned at six institutions. Treatment included (1) Gamma Knife Perfexion (PFX), (2) CyberKnife, (3) Novalis linear accelerator equipped with 3.0-mm multi-leaf collimator (MLC), (4) Varian Truebeam flattening-filter-free (FFF) also 2.5 mm MLC. Identical dose-volume constraints critical structures applied each apparatus. All plans developed individual centers, results centrally analyzed.We found that satisfied by some differences noted in certain as lens. The peripheral normal lowest PFX highest TrueBeam FFF CyberKnife plans. Comparing volumes receiving Gy, FFF, Novalis, 180-290% higher than PFX. mean volume brain-per target 4-Gy increased approximately 3.0 cc per TrueBeam, 2.7 2.0 0.82 beam-on time was shortest (e.g., 6-9 min machine output rate 1,200 MU/min) longest 50-150 mins 350 cGy/min).The 4 Gy higher, more swiftly target, Linac-based SRS times FFF.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (15)
CITATIONS (64)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....